Trial Profile
Double-blind, Randomized, Multicenter, Placebo-controlled Phase II Study of Efficacy and Safety of HMPL-004 in Subjects With Active Moderate Crohn's Disease
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Jan 2020
Price :
$35
*
At a glance
- Drugs HMPL 004 (Primary)
- Indications Crohn's disease
- Focus Therapeutic Use
- 20 Oct 2010 Status changed from recruiting to completed, as results were reported at ACG meeting.
- 20 Oct 2010 Results were presented at the 75th Annual Scientific Meeting of the American College of Gastroenterology
- 07 Oct 2009 New trial record.